FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4213210311> ?p ?o ?g. }

• W4213210311 endingPage "101593" @default.
• W4213210311 startingPage "101593" @default.
• W4213210311 abstract "Cerebral hypoxia-ischemia (CHI) causes brain aging, neurological disorders, cognitive decline, motor function impairment, and mortality. Inhibiting death-associated protein kinase 1 (DAPK1) has shown therapeutic potential against CHI, but several reports contradict its protective function, mechanism of activation, and signal transduction. Here, we systematically reviewed the role and the activation mechanism of DAPK1, and quantitatively assess the efficacy of DAPK1 inhibition (DI) methods in neuroprotection, following a CHI in animal models. Embase and PubMed were searched for relevant studies. Overall, 13 studies met the inclusion criteria, and the SYRCLE Risk of bias tool (RoB) tool was used to assess RoB. StataSE 16 was used for meta-analysis and network meta-analysis (NMA). Standardized mean differences (SMD) with 95% confidence intervals (CI) were calculated to estimate the effect size. DI was associated with the reduction of brain infarct volume (BIV) [SMD = -1.70, 95% CI (-2.10, -1.30); p = 0.00], neurological score (N.S.), neuronal degeneration, with no change in the level of in cell death [SMD = -0.83, 95% CI (-2.00, 0.35); p = 0.17], indicating the protective role of DI against CHI. No differences were found in DAPK1 mRNA and protein levels [SMD = 0.50, 95% CI (-0.05, 1.04); p = 0.07] {single-study driven; upregulated after exclusion (p = 0.01, I2 = 36.43)}, whereas phospho-DAPK1 [SMD = -2.22, 95% CI (-3.69, -0.75); p = 0.00] was downregulated and phosphorylated myosin light chain [SMD = 3.37, 95% CI (2.51, 4.96); p = 0.00] was upregulated between CHI and sham groups. Furthermore, we performed NMA to understand the molecular level at which DI offers maximum protection against BIV. Post-transcriptional inhibition (PTI; SUCRA, 82.6%) and gene knockout showed best (KO; SUCRA, 81.3%), signal transduction inhibition (STI; SUCRA, 49.5%) offered 3rd best, while catalytic activity inhibition (CAI; SUCRA, 0.3%) exhibited the lowest reduction in BIV against CHI. The results demonstrate that DI has a neuroprotective effect against CHI and DAPK1 might be regulated at the post-transcriptional and post-translational levels after CHI. Inhibiting DAPK1 at the post-transcriptional level and blocking multiple signal transduction pathways of DAPK1 could lead to better functional recovery against CHI. AVAILABILITY OF DATA AND MATERIALS: The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request." @default.
• W4213210311 created "2022-02-24" @default.
• W4213210311 creator A5048972302 @default.
• W4213210311 creator A5064077703 @default.
• W4213210311 creator A5077062496 @default.
• W4213210311 creator A5087372145 @default.
• W4213210311 date "2022-04-01" @default.
• W4213210311 modified "2023-10-07" @default.
• W4213210311 title "Neurodegenerative effect of DAPK1 after cerebral hypoxia-ischemia is associated with its post-transcriptional and signal transduction regulations: A systematic review and meta-analysis" @default.
• W4213210311 cites W1493931678 @default.
• W4213210311 cites W1965453486 @default.
• W4213210311 cites W1966134982 @default.
• W4213210311 cites W1972764026 @default.
• W4213210311 cites W1979107365 @default.
• W4213210311 cites W1981250012 @default.
• W4213210311 cites W1986535773 @default.
• W4213210311 cites W1988501212 @default.
• W4213210311 cites W1989190357 @default.
• W4213210311 cites W1992544868 @default.
• W4213210311 cites W1993830305 @default.
• W4213210311 cites W2002782968 @default.
• W4213210311 cites W2007318620 @default.
• W4213210311 cites W2010699829 @default.
• W4213210311 cites W2013900800 @default.
• W4213210311 cites W2014617444 @default.
• W4213210311 cites W2015532779 @default.
• W4213210311 cites W2025877033 @default.
• W4213210311 cites W2026530729 @default.
• W4213210311 cites W2031588422 @default.
• W4213210311 cites W2033585778 @default.
• W4213210311 cites W2033890227 @default.
• W4213210311 cites W2035204555 @default.
• W4213210311 cites W2037593179 @default.
• W4213210311 cites W2037669635 @default.
• W4213210311 cites W2057871351 @default.
• W4213210311 cites W2072929167 @default.
• W4213210311 cites W2076677973 @default.
• W4213210311 cites W2077421021 @default.
• W4213210311 cites W2095515726 @default.
• W4213210311 cites W2098923148 @default.
• W4213210311 cites W2104449396 @default.
• W4213210311 cites W2106622563 @default.
• W4213210311 cites W2107193820 @default.
• W4213210311 cites W2112215250 @default.
• W4213210311 cites W2112970335 @default.
• W4213210311 cites W2113412798 @default.
• W4213210311 cites W2115112698 @default.
• W4213210311 cites W2116033894 @default.
• W4213210311 cites W2124685478 @default.
• W4213210311 cites W2127130842 @default.
• W4213210311 cites W2145923454 @default.
• W4213210311 cites W2146488831 @default.
• W4213210311 cites W2146969546 @default.
• W4213210311 cites W2154499565 @default.
• W4213210311 cites W2155885439 @default.
• W4213210311 cites W2157823046 @default.
• W4213210311 cites W2161701454 @default.
• W4213210311 cites W2560438049 @default.
• W4213210311 cites W2584068329 @default.
• W4213210311 cites W2604940191 @default.
• W4213210311 cites W2607155970 @default.
• W4213210311 cites W2736433134 @default.
• W4213210311 cites W2749870290 @default.
• W4213210311 cites W2767414526 @default.
• W4213210311 cites W2782247629 @default.
• W4213210311 cites W2785332246 @default.
• W4213210311 cites W2795843903 @default.
• W4213210311 cites W2802352303 @default.
• W4213210311 cites W2810742819 @default.
• W4213210311 cites W2811337037 @default.
• W4213210311 cites W2912277841 @default.
• W4213210311 cites W2912547306 @default.
• W4213210311 cites W2955080130 @default.
• W4213210311 cites W2973156172 @default.
• W4213210311 cites W2999727091 @default.
• W4213210311 cites W3011605131 @default.
• W4213210311 cites W3015282949 @default.
• W4213210311 cites W3043459168 @default.
• W4213210311 cites W3082030499 @default.
• W4213210311 cites W3102486286 @default.
• W4213210311 cites W3115880421 @default.
• W4213210311 cites W3149785546 @default.
• W4213210311 cites W3153612365 @default.
• W4213210311 cites W3164022853 @default.
• W4213210311 cites W4206377538 @default.
• W4213210311 doi "https://doi.org/10.1016/j.arr.2022.101593" @default.
• W4213210311 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35202858" @default.
• W4213210311 hasPublicationYear "2022" @default.
• W4213210311 type Work @default.
• W4213210311 citedByCount "7" @default.
• W4213210311 countsByYear W42132103112022 @default.
• W4213210311 countsByYear W42132103112023 @default.
• W4213210311 crossrefType "journal-article" @default.
• W4213210311 hasAuthorship W4213210311A5048972302 @default.
• W4213210311 hasAuthorship W4213210311A5064077703 @default.
• W4213210311 hasAuthorship W4213210311A5077062496 @default.
• W4213210311 hasAuthorship W4213210311A5087372145 @default.
• W4213210311 hasBestOaLocation W42132103111 @default.

• next